Literature DB >> 12115983

Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.

Kanokwan Boonyapisit1, Bashar Katirji.   

Abstract

Vasculitic neuropathy may occur in association with chronic hepatitis C infection. Interferon alpha (IFN(alpha)), an effective treatment for chronic hepatitis C, can precipitate or worsen autoimmune diseases. We report a patient with chronic hepatitis C and mild indolent vasculitic sensorimotor peripheral polyneuropathy, who developed severe mononeuropathy multiplex soon after IFN(alpha) was initiated, and review the literature on worsening vasculitic neuropathy after IFN(alpha) treatment for chronic hepatitis C. Care should be taken after starting patient with chronic hepatitis C-associated vasculitic neuropathy on IFN(alpha), as there is evidence that IFN(alpha) may exacerbate the neuropathy. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115983     DOI: 10.1002/mus.10118

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection.

Authors:  Min-Suk Yoon; Mark Obermann; Christina Dockweiler; Roland Assert; Ali Canbay; Sebastian Haag; Guido Gerken; Hans-Christoph Diener; Zaza Katsarava
Journal:  J Neurol       Date:  2010-08-04       Impact factor: 4.849

2.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

3.  Effect of interferon treatment on hearing of patients with chronic hepatitis C.

Authors:  Abdulrahman Hagr; Dima Jamjoom; Faisal M Sanai; Waleed Al Hamoudi; Ayman A Abdo; Ahmed Al-Arfaj
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

Review 4.  Rheumatic manifestations of hepatitis C infection.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

5.  Rituximab in cryoglobulinemic peripheral neuropathy.

Authors:  Roberto Cavallo; Dario Roccatello; Elisa Menegatti; Carla Naretto; Franca Napoli; Simone Baldovino
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

Review 6.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

7.  Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.

Authors:  Vijay Khiani; Thomas Kelly; Adeel Shibli; Donald Jensen; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 8.  Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature.

Authors:  Wilke Beuthien; Hans-Ullrich Mellinghoff; Johannes von Kempis
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 3.650

9.  Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma.

Authors:  Zohreh Jadali
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

10.  Therapy for vasculitic neuropathies.

Authors:  Kenneth C Gorson
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.